THE CONVERGING FRONTIERS: HOW TECHNOLOGY IS TRANSFORMING THE BATTLE AGAINST CHRONIC RESPIRATORY DISEASES

The future lies in collaborative, patient-centered solutions that deliver measurable outcomes while being accessible and equitable.

- Dr. Shyam Krishnan

Chronic Respiratory Diseases (CRDs) such as COPD, asthma, idiopathic pulmonary fibrosis, bronchiectasis, and lung cancer represent a significant burden to global health. These conditions are often progressive, requiring long-term, resource-intensive care. Fortunately, we are witnessing a remarkable technological renaissance that is reshaping the way we diagnose, monitor, and manage CRDs.

This transformation is not merely about deploying gadgets, it's about improving outcomes, enabling personalized medicine, and building a more sustainable, data-driven respiratory care ecosystem. Dr. Shyam Krishnan

1 Smarter Diagnosis: Al, Biomarkers & Next-Gen Lung Function Testing

Artificial Intelligence in Imaging:

Traditional chest X-ray and CT interpretation is limited by inter-observer variability and time constraints. Al-powered tools, trained on vast imaging datasets, are now enhancing diagnostic accuracy and efficiency. These algorithms can identify early signs of disease or malignancy, especially subtle nodules or fibrosis, prompting earlier intervention. Integration with PACS systems and radiology workflows is already underway in many institutions.

Biomarker Discovery and Liquid Biopsies:

The field of liquid biopsies is gaining momentum, especially in lung cancer. Using non-invasive samples like blood or sputum, molecular markers can now guide diagnosis, prognosis, and therapy selection. These advances are powered by genomic sequencing, proteomics, and bioinformatics, offering clinicians earlier and more precise insights into disease behaviour.

Evolving Pulmonary Function Testing (PFT):